SCHEMBL17632525

SCHEMBL17632525

N#CN(C(=O)C1CCNC1)c1ncc(-c2ccccc2Cl)s1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.41
▸ CHRNB2 P17787 2/20 0.40
▸ CHRNA4 P43681 2/20 0.40
▸ USP30 Q70CQ3 4/20 0.38
▸ CDK9 P50750 1/20 0.36
▸ SLC6A2 P23975 8/20 0.36
▸ SLC6A4 P31645 8/20 0.36
▸ UCHL1 P09936 2/20 0.36
▸ LIMK1 P53667 2/20 0.35
▸ MBTPS1 Q14703 1/20 0.34
▸ SLC6A3 Q01959 5/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ KCNH2 Q12809 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ OPRK1 P41145 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17632937 0.90 CHEK1 (0.37) CHEK1CHRNB2CHRNA4USP30CDK9
SCHEMBL17631847 0.90 USP30 (0.37) CHEK1CHRNB2CHRNA4USP30CDK9
SCHEMBL17632036 0.88 USP30 (0.50) CHEK1USP30UCHL1KCNH2
SCHEMBL17632174 0.86 USP30 (0.36) CHEK1USP30CDK9UCHL1LIMK1
SCHEMBL17631780 0.85 USP30 (0.39) USP30CDK9SLC6A2SLC6A4UCHL1
SCHEMBL17632491 0.84 CHEK1 (0.42) CHEK1USP30SLC6A2SLC6A4UCHL1
SCHEMBL17632150 0.84 USP30 (0.43) CHEK1USP30SLC6A2SLC6A4UCHL1
SCHEMBL17631604 0.83 DYRK1B (0.44) CHEK1USP30UCHL1CYP3A4
SCHEMBL17631685 0.83 DYRK1B (0.44) CHEK1USP30UCHL1CYP3A4
SCHEMBL17631562 0.82 CDK9 (0.34) USP30CDK9UCHL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP claimed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO claimed
Send feedback